ARAVIVE BIOLOGICS Trademark

Trademark Overview

On Wednesday, October 12, 2016, a trademark application was filed for ARAVIVE BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the ARAVIVE BIOLOGICS trademark a serial number of 87200396. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 15, 2020. This trademark is owned by Ruga Corporation. The ARAVIVE BIOLOGICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of cancer, fibrosis, and infectious diseases
aravive biologics

General Information

Serial Number87200396
Word MarkARAVIVE BIOLOGICS
Filing DateWednesday, October 12, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 15, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2017

Trademark Statements

Disclaimer with Predetermined Text"BIOLOGICS"
Goods and ServicesPharmaceutical preparations for use in the treatment of cancer, fibrosis, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 17, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameARAVIVE BIOLOGICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHOUSTON, TX 77010
Party NameARAVIVE BIOLOGICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressHOUSTON, TX 77010
Party NameRuga Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77010

Trademark Events

Event DateEvent Description
Monday, June 15, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 15, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 8, 2019EXTENSION 5 GRANTED
Wednesday, November 6, 2019EXTENSION 5 FILED
Friday, November 8, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 6, 2019TEAS EXTENSION RECEIVED
Wednesday, May 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2019EXTENSION 4 GRANTED
Monday, May 6, 2019EXTENSION 4 FILED
Monday, May 6, 2019TEAS EXTENSION RECEIVED
Friday, October 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 17, 2018EXTENSION 3 GRANTED
Wednesday, October 17, 2018EXTENSION 3 FILED
Wednesday, October 17, 2018TEAS EXTENSION RECEIVED
Friday, April 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 25, 2018EXTENSION 2 GRANTED
Wednesday, April 25, 2018EXTENSION 2 FILED
Wednesday, April 25, 2018TEAS EXTENSION RECEIVED
Wednesday, November 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2017EXTENSION 1 GRANTED
Monday, November 6, 2017EXTENSION 1 FILED
Monday, November 6, 2017TEAS EXTENSION RECEIVED
Tuesday, May 9, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 23, 2017ASSIGNED TO EXAMINER
Wednesday, November 23, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 15, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

biologics aravive infectious diseases fibrosis cancer preparations treatment pharmaceutical